SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Neodyne Biosciences Announces Positive Interim Randomized Control Trial Results for Embrace™ Advanced Scar Therapy, Demonstrating a Highly Significant Difference in Scar Appearance Compared to Standard-of-Care Treatment
Your Message